Date published: 2025-10-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

MAGE-B18 Activators

The activators of MAGE-B18 are a diverse group of compounds that influence a variety of intracellular signaling pathways and mechanisms, culminating in the enhancement of the protein's activity. Through the elevation of intracellular cAMP, certain activators indirectly facilitate the activation of protein kinase A, which is known to phosphorylate substrates and potentially enhance the interaction of MAGE-B18 with components of the ubiquitin-proteasome system, thereby increasing its functional activity. Other activators work by modulating protein kinase C, which can phosphorylate proteins that may alter the subcellular localization or interaction partners of MAGE-B18, leading to an increase in its cellular activity. Additionally, the manipulation of intracellular calcium levels by some activators triggers calcium-dependent kinases and phosphatases, which are capable of modulating the function of MAGE-B18, thus indirectly contributing to its activation.

Certain activators take a different approach by inhibiting phosphodiesterases, thereby preventing the breakdown of cAMP and maintaining elevated levels of this second messenger within the cell. This sustained presence of cAMP results in continued activation of protein kinase A, which, through phosphorylation, could augment the activity of MAGE-B18. Other compounds have been shown to modulate the activity of protein kinase C, either directly or via compensatory mechanisms, leading to the phosphorylation of proteins that may interact with MAGE-B18, therefore enhancing its activity. Furthermore, activators such as polyphenols have been observed to influence various kinase and phosphatase-mediated signaling pathways, which could result in the phosphorylation or dephosphorylation of MAGE-B18, thereby affecting its activation state and function within the cellular milieu.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Elevates intracellular cAMP levels, leading to activation of protein kinase A (PKA). PKA phosphorylation can enhance the activity of MAGE-B18 by promoting its interaction with partners in the ubiquitin-proteasome system.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

Activates protein kinase C (PKC) which can phosphorylate substrates that may alter the subcellular localization or interaction partners of MAGE-B18, thereby increasing its activity within the cell.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$76.00
$265.00
80
(4)

Increases intracellular calcium concentration, which can activate calcium-dependent kinases and phosphatases that modify the function and activity of MAGE-B18.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$27.00
$37.00
5
(0)

Acts as a beta-adrenergic agonist to increase cAMP levels, similarly leading to activation of PKA that may phosphorylate and increase the activity of MAGE-B18.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$45.00
$130.00
$480.00
$4450.00
74
(7)

A cAMP analog that can permeate cell membranes and directly activate PKA, potentially enhancing MAGE-B18 activity through phosphorylation.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$54.00
$128.00
$199.00
$311.00
23
(1)

Calcium ionophore that can mimic ionomycin's effect of increasing intracellular calcium, thereby possibly affecting MAGE-B18 activity via calcium-dependent signaling pathways.

Zaprinast (M&B 22948)

37762-06-4sc-201206
sc-201206A
25 mg
100 mg
$103.00
$245.00
8
(2)

Inhibits phosphodiesterases, leading to increased cAMP levels and subsequent activation of PKA which may phosphorylate and thus activate MAGE-B18.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$75.00
$212.00
18
(1)

A phosphodiesterase inhibitor that elevates cAMP levels, promoting PKA activation and potentially increasing the activity of MAGE-B18 through phosphorylation.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$159.00
$315.00
$598.00
34
(1)

Nonspecific inhibitor of phosphodiesterases, leading to increased cAMP and PKA activation which may positively influence MAGE-B18 activity.

Chelerythrine chloride

3895-92-9sc-3547
sc-3547A
5 mg
25 mg
$88.00
$311.00
17
(1)

PKC inhibitor that can lead to compensatory upregulation of PKC activity, which may indirectly increase the activity of MAGE-B18 through enhanced phosphorylation by activated PKC.